For these experiments, the standard multi-cellular model (3D InSightTM Human Liver MT), was the starting point for the disease initiation models of steatosis and NASH induced by two different treatment schemes: a) steatosis—medium with supraphysiological glucose concentration or b) NASH—diabetic conditions at elevated sugar and insulin levels. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.